Eruptive keratoacanthoma-type squamous cell carcinomas in patients taking sorafenib for the treatment of solid tumors. [electronic resource]
Producer: 20091211Description: 1766-70 p. digitalISSN:- 1524-4725
- Adult
- Antineoplastic Agents -- adverse effects
- Benzenesulfonates -- adverse effects
- Carcinoma, Squamous Cell -- chemically induced
- Female
- Humans
- Keratoacanthoma -- chemically induced
- Male
- Middle Aged
- Neoplasms, Second Primary -- chemically induced
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Protein Kinase Inhibitors -- adverse effects
- Pyridines -- adverse effects
- Skin Neoplasms -- chemically induced
- Sorafenib
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.